In breast tumor-bearing mice, type I IFN directly suppresses the activity of tumor-infiltrating γδ17 T cells, while indirect inhibition of γδ17 T cell-activating factor IL-7 reduces IL-17A secretion through two pathways, thereby impeding tumor progression (68). This evidence concerns the gene IL17A and neoplasm.